Kazazian Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $731K | Hold |
14,424
| – | – | 0.99% | 26 |
|
|
2019
Q2 | $654K | Sell |
14,424
-1,323
| -8% | -$60K | 0.78% | 32 |
|
|
2019
Q1 | $751K | Sell |
15,747
-3,500
| -18% | -$167K | 1.04% | 24 |
|
|
2018
Q4 | $1M | Sell |
19,247
-9,578
| -33% | -$498K | 1.35% | 20 |
|
|
2018
Q3 | $1.79M | Sell |
28,825
-5,010
| -15% | -$311K | 1.68% | 14 |
|
|
2018
Q2 | $1.87M | Buy |
33,835
+15,114
| +81% | +$836K | 1.72% | 13 |
|
|
2018
Q1 | $1.18M | Sell |
18,721
-1,171
| -6% | -$74.1K | 1.24% | 24 |
|
|
2017
Q4 | $1.22M | Sell |
19,892
-2,452
| -11% | -$150K | 1.25% | 21 |
|
|
2017
Q3 | $1.42M | Buy |
22,344
+7,137
| +47% | +$455K | 1.74% | 17 |
|
|
2017
Q2 | $847K | Buy |
15,207
+4,177
| +38% | +$233K | 1.28% | 20 |
|
|
2017
Q1 | $600K | Buy |
+11,030
| New | +$600K | 0.83% | 20 |
|